184 related articles for article (PubMed ID: 12850304)
1. Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen.
Liu Y; Shimizu H; Hashimoto T
J Dermatol Sci; 2003 Aug; 32(2):125-9. PubMed ID: 12850304
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
3. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
5. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
6. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen.
Chen M; O'Toole EA; Sanghavi J; Mahmud N; Kelleher D; Weir D; Fairley JA; Woodley DT
J Invest Dermatol; 2002 Jun; 118(6):1059-64. PubMed ID: 12060403
[TBL] [Abstract][Full Text] [Related]
7. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
Remington J; Chen M; Burnett J; Woodley DT
Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
[TBL] [Abstract][Full Text] [Related]
9. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
10. Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy.
Vodegel RM; de Jong MC; Pas HH; Yancey KB; Jonkman MF
J Am Acad Dermatol; 2003 Apr; 48(4):542-7. PubMed ID: 12664017
[TBL] [Abstract][Full Text] [Related]
11. A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis.
Yamada T; Suzuki M; Koike Y; Kida K; Murata S; Ishii N; Hashimoto T; Ohtsuki M
Dermatology; 2006; 212(4):381-4. PubMed ID: 16707891
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
[TBL] [Abstract][Full Text] [Related]
13. Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.
Pendaries V; Gasc G; Titeux M; Leroux C; Vitezica ZG; Mejía JE; Décha A; Loiseau P; Bodemer C; Prost-Squarcioni C; Hovnanian A
Gene Ther; 2010 Jul; 17(7):930-7. PubMed ID: 20376098
[TBL] [Abstract][Full Text] [Related]
14. Epidermolysis bullosa acquisita: what's new?
Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
[TBL] [Abstract][Full Text] [Related]
15. Intracellular expression of type VII collagen during wound healing in severe recessive dystrophic epidermolysis bullosa and normal human skin.
McGrath JA; Leigh IM; Eady RA
Br J Dermatol; 1992 Oct; 127(4):312-7. PubMed ID: 1419750
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
[TBL] [Abstract][Full Text] [Related]
17. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
Peng TK; Nisengard RJ; Levine MJ; Beutner EH
Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study.
Marzano AV; Cozzani E; Fanoni D; De Pità O; Vassallo C; Berti E; Parodi A; Crosti C; Cugno M
Br J Dermatol; 2013 Jan; 168(1):80-4. PubMed ID: 22913489
[TBL] [Abstract][Full Text] [Related]
19. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
[TBL] [Abstract][Full Text] [Related]
20. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
